title: [Combined drug therapy in patients with chronic otitis media and mucositis].
abstract: The data of the authors own studies using conservative therapy in patients with chronic otitis media (COM) and mucositis are presented. The efficiency of treatment of these patients is shown depending on the method of treatment (the highest efficiency being noted in the main group of patients in whom the altered middle ear mucosa was concurrently exposed to autoserum (AS) and magnetic laser therapy (MLT). The efficiency of this or that conservative treatment was found to be related to the magnitude of altered middle ear mucosal changes: the more marked the signs of mucositis are, the more difficult it is to achieve a positive result. The results of treatment were assessed visually (under an operating microscope), bacteriologically, cytologically, and crystallographically. There was a correlation between the visual assessment of obtained treatment results and crystallographic findings. The high efficiency of the proposed treatment in patients with COM and mucositis is determined by the concurrent combined AS and MLT exposure of the entire thickness of the changed mucosa and by the stimulating action of MLT on AS. This conservative therapy can pretend to be the method of choice in treating patients with COM and mucositis.
authors.forename: V S
authors.initials: VS
authors.lastname: Korviakov
authors.forename: N G
authors.initials: NG
authors.lastname: Sidorina
mesh_terms: D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004427:Ear Diseases / Q000150:complications / Q000473:pathology; D004432:Ear, Middle / Q000473:pathology*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D053685:Laser Therapy; D008280:Magnetics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology; D010033:Otitis Media / Q000150:complications* / Q000628:therapy*; D011810:Quinoxalines / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D011810:Quinoxalines; C001077:dioxidine